2024-11-14T18:46:39-06:00 2024-08-31 814693463 JHS TAX & CONSULTING PO BOX 9500 DANVILLE CA 945260195 990 2023-09-01 942176753 BAY AREA TUMOR INSTITUTE BAYA 5104652242 400 30TH STREET 301 OAKLAND CA 94609 BARRY SIEGEL PRESIDENT 5104658571 2024-11-14 1 0 JAMES F KEPKE P00043916 9258201821 2023 2024-10-15 13:58:12Z BARRY SIEGEL 400 30TH STREET STE 301 OAKLAND CA 94609 3744000 0 X WWW.BATI.ORG X 1972 CA CANCER PREVENTION AND IMPROVED PATIENT CARE THROUGH CLINICAL RESEARCH 12 11 7 0 -19049 0 1021318 673496 21045 16730 44528 60646 5561 1136 1092452 752008 0 0 0 0 910134 1723452 0 0 0 404304 373238 1314438 2096690 -221986 -1344682 1909102 464657 112654 12891 1796448 451766 CANCER PREVENTION AND IMPROVED PATIENT CARE THROUGH CLINICAL RESEARCH 0 0 1647710 669171 CANCER RESEARCH 71587 CANCER PATIENT SERVICES 357355 16730 CANCER EDUCATION AND TRAINING FOR PROFESSIONALS 2076652 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 4 0 7 0 0 0 0 0 0 0 0 0 0 0 X 12 11 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA X JEANNE OLSEN 5104652242 400 30TH STREET SUITE 301 OAKLAND CA 94609 KELLIE JOHNSON ABREU CHAIR, BOARD OF DIRECTORS 1.00 X 0 0 0 JON M GREIF DO FACS DIRECTOR 1.00 X 0 0 0 LIGAYA YADAO RN MS CNS DIRECTOR 1.00 X 0 0 0 NANCEE M HIRANO RN MS ANP AOCN DIRECTOR 1.00 X 0 0 0 MRS ROBERT C HOOVER DIRECTOR 1.00 X 0 0 0 LINDA KELLY LCSW DIRECTOR 1.00 X 0 0 0 TOM K LEE MD DIRECTOR 1.00 X 0 0 0 ANGELES PRICE RN MS CNS AOCN DIRECTOR 1.00 X 0 0 0 BRENDA SHANK MD PHD DIRECTOR 1.00 X 0 0 0 MR WILLIAM A QUINBY DIRECTOR 1.00 X 0 0 0 LISA BAILEY MD FACS DIRECTOR 1.00 X 0 0 0 BARRY BSIEGEL20232024 W-2 SALARY,BONUS,OTHER)PRESIDENT 40.00 X 1033699 0 0 JENNIFER KIM-HASSEL20232024 W2 SALARY,OTHER)CLINICAL RESEARCH ASSO 40.00 X 179245 0 0 MELODY JCHIN20232024 W-2 SALARY,OTHER)CLINICAL RESEARCH ASSO 40.00 X 178943 0 0 SHARON MOMEGA20232024 W-2 SALARY,OTHER)DIRECTOR CLINICAL RESEARCH 40.00 X 475929 0 0 JOANNE V HEATH20232024 W-2 SALARY,OTHER)CLINICAL RESEARCH ASSO 40.00 X 269312 0 0 2137128 0 0 5 0 1 0 0 669171 4325 673496 FEES FOR SERVICE 621300 16730 16730 16730 79695 79695 2972943 2991992 -19049 -19049 -19049 OTHER INCOME 621300 1136 1136 1136 752008 16730 -19049 80831 1605448 1586987 18461 24661 24661 16117 16117 77226 76149 1077 46915 46915 85053 85053 9042 9042 11620 11620 79387 79387 5139 5139 1403 1403 13451 13451 CONSORTIUM AGREEMENT 118396 118396 REPAIRS & MAINTENANCE 2832 2332 500 2096690 2076652 20038 0 159258 463817 88720 0 21166 223347 222507 2243 840 1591445 46270 0 1909102 464657 50192 12891 14799 0 47663 0 112654 12891 X 1796448 451766 1796448 451766 1909102 464657 -1344682 0 X 0 0 0 X 1046343 984158 969131 1042363 691362 4733357 1046343 984158 969131 1042363 691362 4733357 4733357 44271 21957 9754 44484 60646 181112 4914469 0.96310 0.97100 X 17034 17035 -1 166826 166261 565 39487 39211 276 840 X 752008 0 752008 0 752008 0 0 0 0 0 PART X, LINE 2: THE INSTITUTE DID NOT HAVE UNRECOGNIZED TAX LIABILITIES AS OF AUGUST 31, 2024, AND DOES NOT EXPECT THIS TO CHANGE OVER THE NEXT 12 MONTHS. X X 1 0 0 0 0 0 0 0 0 BARRY BSIEGEL20232024 W-2 SALARY,BONUS,OTHER)PRESIDENT 531777 0 50000 0 451922 0 0 0 0 0 1033699 0 0 0 SHARON MOMEGA20232024 W-2 SALARY,OTHER)DIRECTOR CLINICAL RESEA 352569 0 0 0 123360 0 0 0 0 0 475929 0 0 0 JOANNE V HEATH20232024 W-2 SALARY,OTHER)CLINICAL RESEARCH ASSO 155169 0 0 0 114143 0 0 0 0 0 269312 0 0 0 JENNIFER KIM-HASSEL20232024 W2 SALARY,OTHER)CLINICAL RESEARCH AS 159822 0 0 0 19423 0 0 0 0 0 179245 0 0 0 MELODY JCHIN20232024 W-2 SALARY,OTHER)CLINICAL RESEARCH ASSO 150135 0 0 0 28808 0 0 0 0 0 178943 0 0 0 PART I, LINE 4A ON OCTOBER 27, 2023, THE BAY AREA TUMOR INSTITUTE'S BOARD OF DIRECTORS UNANIMOUSLY APPROVED THE DISSOLUTION OF THE ORGANIZATION AND ALL OF ITS ASSETS, TO TAKE PLACE ON OR ABOUT DECEMBER 31, 2024. THE TARGET DATES WERE SUBSEQUENTLY CHANGED TO APRIL 1, 2024 FOR TERMINATION OF THE CLINICAL RESEARCH PROGRAM AND JUNE 30, 2024 FOR ALL OTHER MATTERS. ALTHOUGH ALL OF THE DEFINED TASKS FOR WHICH THE RETENTION/SEVERANCE PAYMENTS WERE AGREED-UPON WERE COMPLETED PRIOR TO JUNE 30, 2024, UNEXPECTED DELAYS BY THE OFFICES OF THE CALIFORNIA SECRETARY OF STATE AND THE STATE ATTORNEY GENERAL, HAVING NOTHING TO DO WITH OUR DOCUMENTS, CREATED A CASCADE OF DELAYS THAT PREVENTED THE CLOSURE OF OUR CORPORATION UNTIL DECEMBER 2024. PREVIOUSLY, MANAGEMENT GAVE THE BOARD A DETAILED STATEMENT OF OPERATIONAL CLOSEOUT PROCEDURES AND REVIEWED THE COMPLEX NATURE OF THE CANCER RESEARCH PROGRAM, AND OF THE NEED FOR ALL STAFF TO CONTINUE THEIR EMPLOYMENT SO THAT THE INSTITUTE COULD FULFILL ITS LEGAL AND ETHICAL "PATIENT CONSENT" OBLIGATIONS TO ALL ADULT AND PEDIATRIC CANCER PATIENTS INVOLVED IN CLINICAL RESEARCH, THEIR TREATING PHYSICIANS, PARTICIPATING HOSPITALS, THE NATIONAL CANCER INSTITUTE, THE FDA AND OTHER INVOLVED FEDERAL AGENCIES. IN ORDER TO RETAIN ITS HIGHLY SKILLED AND LONG-DURATION EMPLOYEES, THE BOARD (COMPOSED OF ONCOLOGY PHYSICIANS, ONCOLOGY NURSES, AN ONCOLOGY SOCIAL WORKER, BUSINESS PROFESSIONALS, AN ATTORNEY AND MEMBERS OF THE NONMEDICAL PUBLIC), DISCUSSED THE NEED FOR A RETENTION AND SEVERANCE POLICY FOR THE PROFESSIONAL STAFF WITHOUT WHOM THE RESEARCH COULD NOT BE ETHICALLY TERMINATED. THE BOARD, IN EXECUTIVE SESSION WITHOUT STAFF PRESENT, REVIEWED NUMEROUS RETENTION/SEVERANCE DOCUMENTS FROM HUMAN RESOURCE PROFESSIONAL ASSOCIATIONS THAT DESCRIBED CURRENT"BEST PRACTICE" STANDARDS IN THE NONPROFIT FIELD (STANDARDS RANGED BETWEEN 1-4 WEEKS OF SEVERANCE PER YEAR OF EMPLOYMENT), AND THE BOARD CHOSE TO REMAIN IN THE LOWER HALF OF THAT RANGE. CONSISTENT WITH THIS RESEARCH, THE BOARD DESIGNED AND APPROVED A NONDISCRIMINATORY RETENTION/SEVERANCE PLAN, SIGNED BY EACH EMPLOYEE, THAT AWARDED 2 WEEKS OF SALARY FOR EVERY YEAR OF EMPLOYMENT FOR THOSE WHO STAYED AND COMPLETED THEIR AGREED-UPON RESPONSIBILITIES. THE EXPENSE OF THE TOTAL PACKAGE WAS APPROXIMATELY $755,000 AND WAS UNANIMOUSLY APPROVED BY THE BOARD. NO FEDERAL FUNDS WERE USED TO PAY FOR THIS PURPOSE. FOLLOWING ARE DETAILS OF THE SEVERANCE PAYMENTS INCLUDED IN SCH J, PART II, B (III)OTHER REPORTABLE COMPENSATION: BARRY B. SIEGEL, PRESIDENT: 2024 GROSS SEVERANCE PAYMENT WAS $451,922 SHARON M.OMEGA,DIRECTOR CLINICAL RESEARCH: 2024 GROSS SEVERANCE PAYMENT WAS $123,360 JOANNE V. HEATH, CLINICAL RESEARCH ASSOCIATE: 2024 GROSS SEVERANCE PAYMENT WAS $114,143 JENNIFER KIM-HASSEL, CLINICAL RESEARCH ASSOCIATE: 2024 GROSS SEVARANCE PAYMENT IS $19,423 MELODY J. CHIN, CLINICAL RESEARCH ASSOCIATE: 2024 GROSS SEVERANCE PAYMENT WAS $28,808 LEAH E. RADKE, ADMIN SECRETARY: 2024 GROSS SEVERANCE PAYMENT WAS $4,688 FORM 990,SCH J, PART II (B)(I)BASE COMPENSATION: THE BASE COMPENSATION INCLUDED IN THE ABOVE SCHEDULE J CONSISTS OF EACH EMPLOYEES REGULAR COMPENSATION FROM CALENDAR YEAR 2023 FORM W-2 (FROM 01/01/23 THROUGH 12/31/23) PLUS REGULAR COMPENSATION FOR THE PERIOD FROM 01/01/2024 THROUGH 08/31/2024. SO, A TOTAL 20 MONTHS OF COMPENSATION INCLUDED IN THE ABOVE BASE COMPENSATION BOX. FORM 990, PART VI, SECTION A, LINE 7A THE INSTITUTE HAS A NOMINATING COMMITTEE THAT USES A FOUR OBJECTIVE CRITERIA TO DETERMINE WHICH CURRENT BOARD MEMBERS WHO'S TERM IS EXPIRING HAS SATISFIED HIS/HER RESPONSIBILITIES AND IS AVAILABLE TO BE RE-NOMINATED. THE NOMINATING COMMITTEE ALSO DETERMINES THE NUMBER OF OPEN BOARD SEATS THAT MAY BECOME AVAILABLE TO FILL, AND THEN ASKS THE REMAINING MEMBERS OF THE BOARD OF DIRECTORS FOR NOMINATIONS OF INDIVIDUALS THAT WILL BE WILLING AND ABLE TO SERVE. FORM 990, PART VI, SECTION B, LINE 11B COPIES OF THE DRAFT FORM 990 WERE PROVIDED FOR REVIEW BY THE BOARD OF DIRECTORS VIA BOARD MEETING OR EMAIL. FORM 990, PART VI, SECTION B, LINE 12C THE INSTITUTE REQUIRES EACH DIRECTOR, OFFICER AND MEMBER OF A COMMITTEE TO SIGN A CONFLICT OF INTEREST POLICY AFFIRMATION ANNUALLY, WHICH IS SUBJECT TO PERIODIC REVIEW. FORM 990, PART VI, SECTION B, LINE 15A THE COMPENSATION OF THE INSITUTES PRESIDENT, BARRY SIEGEL, IS A CONTRACTUALLY AGREED UPON AMOUNT APPROVED BY THE BOARD OF DIRECTORS WITH ADDITIONALLY APPROVED ANNUAL INCREASES. THE CHAIR OF THE BOARD OF DIRECTORS MAY AT HIS/HER DISCRETION DETERMINE A BONUS AS PART OF THE ANNUAL PERFORMANCE EVALUATION FOR ALL EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 UPON ADVANCE NOTICE, ALL GOVERNING AND SUPPORTING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC.